Metformin and Hair Loss: The B12 Connection
Metformin is one of the most widely prescribed medications in the world, used for type 2 diabetes, prediabetes, polycystic ovary syndrome (PCOS), and weight management. Hair loss is not on the prominent side-effect list most patients see, but a real association exists through a specific and well-documented mechanism: long-term metformin use can reduce vitamin B12 absorption, and B12 deficiency can drive hair shedding. The mechanism matters because it is treatable without stopping metformin.
This page covers what is happening biologically, what the evidence shows, how to test for the deficiency, and what to do.
The B12 mechanism
Vitamin B12 is absorbed in the terminal ileum, the last part of the small intestine, through a process that requires intrinsic factor (a protein secreted by the stomach lining) and calcium-dependent uptake mechanisms. Metformin appears to interfere with the calcium-dependent step, reducing B12 absorption over time.
The clinical consequence is a slow drift toward B12 deficiency in long-term metformin users. The largest meta-analyses and cohort studies suggest the prevalence of B12 deficiency in patients on metformin for five years or more is in the range of 10 to 30 percent, depending on the threshold used and the population studied. The risk is dose-related and duration-related: higher doses and longer use mean higher deficiency rates.
B12 deficiency, in turn, can cause hair shedding through its effects on cellular metabolism. B12 is essential for DNA synthesis, and the rapidly dividing matrix cells in hair follicles are particularly sensitive to disruption. Deficiency typically presents as a diffuse telogen-effluvium-style shedding, sometimes alongside the more classic features of B12 deficiency: fatigue, glossitis (smooth, sore tongue), neurological symptoms (tingling in extremities, balance problems), or macrocytic anemia (large red blood cells) on a CBC.
How strong is the evidence for hair loss specifically
The evidence linking B12 deficiency to hair shedding is reasonably solid in the dermatology literature, though the absolute contribution to any given case is variable. Case series of patients with diffuse hair shedding routinely include a subset with documented B12 deficiency where supplementation produces measurable improvement. The mechanism is biologically plausible and the time course (months from deficiency onset to visible shedding) fits.
Linking metformin specifically to hair loss requires the chain: metformin causes B12 deficiency, and B12 deficiency causes hair loss. Each link is well-established individually. Direct studies of metformin and hair loss as endpoints are limited, but the indirect chain is strong enough that the hair-loss community and many primary-care physicians routinely include B12 in the workup of metformin users with diffuse shedding.
What to test
The standard lab is serum B12. The ranges are:
- Normal: typically above 300 pg/mL (though labs vary)
- Borderline: 200 to 300 pg/mL
- Deficient: below 200 pg/mL
The complicating factor is that serum B12 can be misleadingly normal in some patients who have functional B12 deficiency at the cellular level. The more sensitive markers are:
- Methylmalonic acid (MMA): rises when B12 is functionally deficient
- Homocysteine: also rises in B12 (and folate) deficiency
For a patient on long-term metformin with diffuse hair shedding and a borderline B12, the additional markers (MMA, homocysteine) can resolve the picture. If both are elevated, B12 deficiency is real even if the serum B12 looks acceptable.
A focused panel for a metformin patient with hair shedding usually includes serum B12 (with reflex MMA if borderline), ferritin, TSH, free T4, vitamin D, and a CBC.
What to do if B12 is low
Treatment depends on the severity of the deficiency and on whether absorption is still working.
Mild to moderate deficiency in a patient who is otherwise well: oral B12 supplementation at 1000 to 2000 mcg daily is usually sufficient. Cyanocobalamin or methylcobalamin both work; methylcobalamin is the active form and is sometimes preferred. Even with reduced absorption from metformin, the high oral dose typically saturates the deficient state.
Severe deficiency, neurological symptoms, or evidence of intestinal absorption failure: intramuscular B12 injections (1000 mcg weekly for several weeks, then monthly) are the standard approach. This bypasses absorption issues entirely.
Borderline B12 with elevated MMA: oral supplementation is reasonable to try first, with follow-up labs in three months to confirm response.
Most patients respond to supplementation within weeks at the lab level, with hair changes (if B12 was the relevant driver) showing improvement over the following three to six months as the follicles cycle through telogen and back into anagen with adequate substrate.
Do not stop metformin without a physician
For most patients on metformin, the medication is being used for an important reason: diabetes management, PCOS, or weight management. Stopping it independently to test for hair-loss attribution is not the right move, particularly because the deficiency can usually be corrected with supplementation while continuing the metformin.
If the B12 supplementation does not resolve the hair loss within six to nine months, the conversation with the prescribing physician shifts to whether other contributors are present (iron, thyroid, coexisting pattern hair loss) and whether any modifications to the metformin regimen are reasonable.
Other things metformin patients should check
Beyond B12, a few other contributors are worth ruling out in any metformin user with hair shedding:
- Iron and ferritin. Iron deficiency is common in menstruating women, particularly those with PCOS on metformin who also have heavy or irregular periods.
- Thyroid function. Hypothyroidism can drive diffuse shedding and is a frequent comorbidity in metabolic syndrome populations.
- Coexisting androgenetic alopecia. PCOS-related elevated androgens can drive female pattern hair loss alongside any B12-mediated telogen effluvium. The two have different patterns and respond to different treatments. Our PCOS page covers the AGA dimension.
A focused medical evaluation with a U.S.-licensed physician can sort the differential and recommend a plan that addresses each contributor.
The general framework
The metformin and hair-loss picture is a good example of how drug-induced hair loss often plays out in practice. The mechanism is specific and well-understood. The treatment is targeted at the mechanism (correcting the deficiency) rather than at the medication. The hair effect is recoverable when the underlying contributor is addressed. And the analysis benefits from a structured workup rather than self-experimentation with stopping the drug.
For a broader framework on medication-related hair loss, see the drug-induced hair loss pillar and the medications as a cause of hair loss page in the causes cluster. To start a structured evaluation with a U.S.-licensed physician, Curekey's hair assessment is one starting point.
